OVERVIEW

CME: Updates in psoriasis management: Contemporary practice and novel therapies is organized by ScientiaCME.

Release Date: October 05, 2021
Expiration Date: October 05, 2023

Activity Description / Statement of Need:
In this online, self-learning activity:
Psoriasis, characterized by chronic inflammation of the skin and hyperproliferation and abnormal differentiation of the stratified epidermis, is one of the most common autoimmune diseases in the US. With a clinical presentation of red, scaly plaques on the skin that range in severity from minor, localized lesions to complete body coverage, it is also associated with inflammation of the joints and enthesial attachments and has the potential for articular destruction—a complication known as psoriatic arthritis that affects up to 30% of those with the disease. Aside from its direct effects on the skin, it also reduces the quality of life associated with cardiac and psychiatric comorbidities. Over half of patients with psoriasis are unsatisfied with their disease management, and half of the patients with mild disease are untreated while the same is true for a fifth of patients with severe disease.

This activity has been designed to bring HCPs’ knowledge of current and emerging screening and treatment strategies for psoriasis up to date and to improve their competence and performance in treating it. This program has also been designed to review treatment strategies and raise awareness of gaps in the care of patients with psoriasis and review strategies to promote adherence.

Learning Objectives:
By the end of the session the participant will be able to:
• Recall the comorbidity-, diagnostic-, and treatment-related healthcare burdens associated with psoriasis.
• Identify the currently available and emerging pharmacotherapeutic treatments for the management of psoriasis.
• Formulate a treatment plan for a patient with psoriasis, including treatment of the primary and associated diseases.